CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
516.92MUSDvs all stocks (USD)
Revenue (TTM)
50.27MUSDvs all stocks (USD)
Profit Margin
-137.08%Beta
1.45xvs all stocks
52-Week Change
-2.60%vs all stocks
Market Capitalization
516.92MUSDvs all stocks (USD)
Enterprise Value
428.37MUSDvs all stocks (USD)
Forward P/E
-8.76xPrice to Sales (TTM)
9.83xEnterprise to Revenue
8.52xEnterprise to EBITDA
-7.74xGross Margin
75.99%Profit Margin
-137.08%Operating Margin
-29.10%Return on Assets (TTM)
-28.71%Revenue (TTM)
50.27MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.4420USDUpdated Jul 18, 2026Quarterly Revenue Growth
65.70%Gross Profit (TTM)
31.90MUSDvs all stocks (USD)
EBITDA (TTM)
-55.34MUSDvs all stocks (USD)
Net Income (TTM)
-68.91MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
65.67%Operating Cash Flow (TTM)
-43.84MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-25.69MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
44.55MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
18.55MUSDFY2025 · Dec 31, 2025Gross Profit
25.99MUSDFY2025 · Dec 31, 2025Operating Income
-71.05MUSDvs all stocks (USD)
Pre-tax Income
-83.78MUSDFY2025 · Dec 31, 2025Income Tax Expense
0.00USDFY2025 · Dec 31, 2025Net Income
-83.78MUSDFY2025 · Dec 31, 2025EBIT
-66.68MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-66.14MUSDFY2025 · Dec 31, 2025Research & Development
17.19MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
79.85MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
4.37MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
17.10MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
-83.78MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-56.16MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
121.17MUSDFY2025 · Dec 31, 2025Income Tax Paid
0.00USDFY2025 · Dec 31, 2025Interest Paid
6.10MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-83.78MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
548.00KUSDFY2025 · Dec 31, 2025Stock-based Compensation
7.62MUSDFY2025 · Dec 31, 2025Other Non-cash Items
11.00MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-10.37MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
19.52MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-697.00KUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-26.00KUSDFY2025 · Dec 31, 2025Other Financing Charges
-821.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
99.81MUSDFY2025 · Dec 31, 2025Shares Outstanding
124.28MSharesUpdated Jul 18, 2026Float Shares
114.57MSharesUpdated Jul 18, 2026Shares Short
16.00MSharesUpdated Jul 18, 2026Short Ratio
7.02daysvs all stocks
Short % of Shares Outstanding
13.35%vs all stocks
% Held by Insiders
3.09%vs all stocks
% Held by Institutions
58.79%vs all stocks
Total Cash (MRQ)
110.73MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.8830USDUpdated Jul 18, 2026Total Debt (MRQ)
43.58MUSDvs all stocks (USD)
Current Ratio (MRQ)
4.10xBook Value per Share (MRQ)
-0.2740USDUpdated Jul 18, 2026Total Assets
160.43MUSDvs all stocks (USD)
Total Current Assets
149.27MUSDFY2025 · Dec 31, 2025Total Liabilities
194.09MUSDFY2025 · Dec 31, 2025Total Non-current Assets
11.16MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
146.48MUSDFY2025 · Dec 31, 2025Total Current Liabilities
47.61MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
121.17MUSDFY2025 · Dec 31, 2025Accounts Receivable
8.01MUSDFY2025 · Dec 31, 2025Inventory
6.17MUSDFY2025 · Dec 31, 2025Accounts Payable
29.86MUSDFY2025 · Dec 31, 2025Short-term Debt
10.63MUSDFY2025 · Dec 31, 2025Deferred Revenue
1.09MUSDFY2025 · Dec 31, 2025Other Current Liabilities
1.00MUSDFY2025 · Dec 31, 2025Long-term Debt
31.86MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
33.21MUSDFY2025 · Dec 31, 2025Common Stock (Book)
122.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-447.00MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
-33.66MUSDvs all stocks (USD)
52-Week Low
2.93USDUpdated Jul 18, 202652-Week High
7.55USDUpdated Jul 18, 202652-Week Change
-2.60%vs all stocks
Beta
1.45xvs all stocks
50-Day MA
4.22USDUpdated Jul 18, 2026200-Day MA
4.83USDUpdated Jul 18, 2026Avg 10-Day Volume
1.45MSharesUpdated Jul 18, 2026Avg 30-Day Volume
2.01MSharesUpdated Jul 18, 2026Diluted EPS (TTM)
-0.6100USDUpdated Jul 18, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.76Profit Margin: -1.37
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Arvinas Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Lifecome Biochemistry Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zura Bio Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Eiken Chemical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Aim Vaccine Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
IOL Chemicals and Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Pharmicell Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Regenxbio Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Tibet Aim Pharm Inc.
Tier 1ProductionApproval-Gated PipelineRule